Dimensional Fund Advisors LP Grows Position in The Clorox Company $CLX

Key Points

• Dimensional Fund Advisors LP increased its stake in The Clorox Company by 0.6%, owning 936,393 shares valued at approximately $137.88 million after acquiring an additional 5,365 shares.
• The Clorox Company reported a quarterly earnings per share of $2.87, significantly beating the consensus estimate of $2.24, and had a revenue increase of 4.5% year-over-year.
• Clorox declared a quarterly dividend of $1.24 per share, reflecting a positive increase from the previous dividend, with an annualized yield of 4.1% for shareholders.

Dimensional Fund Advisors LP grew its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 0.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 936,393 shares of the company's stock after buying an additional 5,365 shares during the quarter. Dimensional Fund Advisors LP owned 0.76% of Clorox worth $137,879,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also bought and sold shares of the company. Sonora Investment Management Group LLC lifted its stake in shares of Clorox by 2.5% during the first quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after buying an additional 72 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Clorox by 0.6% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock valued at $1,953,000 after purchasing an additional 73 shares in the last quarter. Horizon Investments LLC grew its holdings in Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock valued at $258,000 after purchasing an additional 75 shares in the last quarter. Sfmg LLC increased its position in shares of Clorox by 2.8% in the 1st quarter. Sfmg LLC now owns 2,780 shares of the company's stock worth $409,000 after purchasing an additional 76 shares during the last quarter. Finally, Financial Avengers Inc. increased its position in shares of Clorox by 32.1% in the 4th quarter. Financial Avengers Inc. now owns 457 shares of the company's stock worth $74,000 after purchasing an additional 111 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

CLX stock traded down $0.2810 during midday trading on Tuesday, reaching $119.1090. 301,292 shares of the company were exchanged, compared to its average volume of 1,631,749. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a market capitalization of $14.57 billion, a price-to-earnings ratio of 18.27, a price-to-earnings-growth ratio of 0.96 and a beta of 0.49. The Clorox Company has a one year low of $117.35 and a one year high of $171.37. The business has a 50-day moving average price of $124.16 and a two-hundred day moving average price of $135.01.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This is a positive change from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.2%. Clorox's payout ratio is currently 76.07%.

Analysts Set New Price Targets

A number of research analysts have issued reports on CLX shares. Citigroup reissued a "neutral" rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Morgan Stanley cut their target price on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. UBS Group lowered their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Finally, Jefferies Financial Group reduced their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. One analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Reduce" and a consensus price target of $143.36.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.